RXST ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of RxSight, Inc. Investors
July 23, 2025 5:17 PM EDT | Source: Kirby McInerney LLP
New York, New York--(Newsfile Corp. - July 23, 2025) - The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST) securities during the period of November 7, 2024 through July 8, 2025, inclusive ("the Class Period"). Investors have until September 22, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
[LEARN MORE ABOUT THE CLASS ACTION]
On July 8, 2025, RxSight reported preliminary second quarter 2025 financial results, revealing significant declines in sales, utilization, and revenue. The Company also lowered its full year 2025 guidance by approximately $42.5 million at the midpoint. The Company's Chief Executive Officer, Ronald Kurtz attributed the lower sales to "adoption challenges over the last few quarters." On this news, the price of RxSight shares declined by $4.84, or approximately 37.8%, to close at $7.95 per share on July 9, 2025.
The lawsuit alleges that RxSight failed to disclose to investors that: (1) the Company was experiencing "adoption challenges" and structural issues resulting in declines in sales and utilization; (2) RxSight had overstated the demand for its products; and (3) as a result, RxSight was unlikely to meet its own previously issued financial guidance for fiscal year 2025.
If you purchased or otherwise acquired RxSight securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters without any cost to you.
Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP's website.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/259874